Todd Klein has had an extensive career in sales and marketing, starting as a Sales Rep at AstraZeneca before moving on to become an Executive Sales Specialist at Novartis. Currently, Todd works as a Cardio-Metabolic Sales Specialist at VIVUS, Inc. where Todd launched Qsymia, the first treatment for obesity to hit the market in 13 years. With a BAM in Business & Marketing from the University of Phoenix and an MBA in Business Management & Marketing, Todd has consistently exceeded sales quotas and built strong relationships with clients throughout their career.